Stay updated on Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study record for the phase II mucosal melanoma trial is displayed, including its ipilimumab and nivolumab regimen, participant criteria, study locations, and record information.
    Difference
    54%
    Check dated 2026-11-10T13:58:26.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T13:59:08.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    A site-wide NIH notice explains the transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision advances from v3.7.1 to v3.7.2. The study page continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-20T14:22:02.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-13T14:33:18.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The Study Record page now shows a 403 Forbidden error instead of the usual study details, indicating an access issue rather than content changes.
    Difference
    19%
    Check dated 2026-09-22T21:00:15.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision labeled as v3.7.0 replaces the previous v3.6.6. This appears to be a maintenance version update without affecting the study information displayed on the page.
    Difference
    0.1%
    Check dated 2026-09-15T21:48:07.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in Mucosal Melanoma Clinical Trial page.